ATC Group: J07BC Hepatitis vaccines

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07BC in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07B Viral vaccines
4 J07BC Hepatitis vaccines

Group J07BC contents

Code Title
J07BC01 Hepatitis B, purified antigen
J07BC02 Hepatitis A, inactivated, whole virus
J07BC20 Combinations

Active ingredients in J07BC

Active Ingredient

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate.

Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer.

Related product monographs

Document Type Information Source  
 AMBIRIX Suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 AVAXIM Suspension for injection in a prefilled syringe MPI, EU: SmPC Υπουργείο Υγείας (CY)
 ENGERIX-B Suspension for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 FENDRIX Suspension for injection MPI, EU: SmPC European Medicines Agency (EU)
 HBVAXPRO Suspension for injection MPI, EU: SmPC European Medicines Agency (EU)
 HEPLISAV B Solution for injection in pre-filled syringe MPI, EU: SmPC European Medicines Agency (EU)
 RECOMBIVAX HB Suspension for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 VAQTA ADULT Suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 VAQTA PAEDIATRIC Suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)